Literature DB >> 18205354

Inactivation of microbial arginine deiminases by L-canavanine.

Ling Li1, Zhimin Li, Danqi Chen, Xuefeng Lu, Xiaohua Feng, Elizabeth C Wright, Nathan O Solberg, Debra Dunaway-Mariano, Patrick S Mariano, Andrey Galkin, Liudmila Kulakova, Osnat Herzberg, Kari B Green-Church, Liwen Zhang.   

Abstract

Arginine deiminase (ADI) catalyzes the hydrolytic conversion of L-arginine to ammonia and L-citrulline as part of the energy-producing L-arginine degradation pathway. The chemical mechanism for ADI catalysis involves initial formation and subsequent hydrolysis of a Cys-alkylthiouronium ion intermediate. The structure of the Pseudomonas aeruginosa ADI-(L-arginine) complex guided the design of arginine analogs that might react with the ADIs to form inactive covalent adducts during catalytic turnover. One such candidate is L-canavanine, in which an N-methylene of L-arginine is replaced by an N-O. This substance was shown to be a slow substrate-producing O-ureido-L-homoserine. An in depth kinetic and mass spectrometric analysis of P. aeruginosa ADI inhibition by L-canavanine showed that two competing pathways are followed that branch at the Cys-alkylthiouronium ion intermediate. One pathway leads to direct formation of O-ureido-L-homoserine via a reactive thiouronium intermediate. The other pathway leads to an inactive form of the enzyme, which was shown by chemical model and mass spectrometric studies to be a Cys-alkylisothiourea adduct. This adduct undergoes slow hydrolysis to form O-ureido-L-homoserine and regenerated enzyme. In contrast, kinetic and mass spectrometric investigations demonstrate that the Cys-alkylthiouronium ion intermediate formed in the reaction of L-canavanine with Bacillus cereus ADI partitions between the product forming pathway (O-ureido-L-homoserine and free enzyme) and an inactivation pathway that leads to a stable Cys-alkylthiocarbamate adduct. The ADIs from Escherichia coli, Burkholderia mallei, and Giardia intestinalis were examined in order to demonstrate the generality of the L-canavanine slow substrate inhibition and to distinguish the kinetic behavior that defines the irreversible inhibition observed with the B. cereus ADI from the time controlled inhibition observed with the P. aeruginosa, E. coli, B. mallei, and G. intestinalis ADIs.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18205354     DOI: 10.1021/ja0760877

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  17 in total

Review 1.  The Taxonomy of Covalent Inhibitors.

Authors:  Alfred Tuley; Walter Fast
Journal:  Biochemistry       Date:  2018-04-30       Impact factor: 3.162

2.  Born-Oppenheimer ab initio QM/MM molecular dynamics simulations of the hydrolysis reaction catalyzed by protein arginine deiminase 4.

Authors:  Zhihong Ke; Shenglong Wang; Daiqian Xie; Yingkai Zhang
Journal:  J Phys Chem B       Date:  2009-12-31       Impact factor: 2.991

Review 3.  Mechanistic similarity and diversity among the guanidine-modifying members of the pentein superfamily.

Authors:  Thomas Linsky; Walter Fast
Journal:  Biochim Biophys Acta       Date:  2010-07-21

4.  Substrate specificity and kinetic studies of PADs 1, 3, and 4 identify potent and selective inhibitors of protein arginine deiminase 3.

Authors:  Bryan Knuckley; Corey P Causey; Justin E Jones; Monica Bhatia; Christina J Dreyton; Tanesha C Osborne; Hidenari Takahara; Paul R Thompson
Journal:  Biochemistry       Date:  2010-06-15       Impact factor: 3.162

5.  Mechanistic studies of agmatine deiminase from multiple bacterial species.

Authors:  Justin E Jones; Christina J Dreyton; Heather Flick; Corey P Causey; Paul R Thompson
Journal:  Biochemistry       Date:  2010-11-02       Impact factor: 3.162

6.  Ab initio QM/MM free-energy studies of arginine deiminase catalysis: the protonation state of the Cys nucleophile.

Authors:  Zhihong Ke; Hua Guo; Daiqian Xie; Shenglong Wang; Yingkai Zhang
Journal:  J Phys Chem B       Date:  2011-03-11       Impact factor: 2.991

Review 7.  Bacterial and human peptidylarginine deiminases: targets for inhibiting the autoimmune response in rheumatoid arthritis?

Authors:  Pamela Mangat; Natalia Wegner; Patrick J Venables; Jan Potempa
Journal:  Arthritis Res Ther       Date:  2010-06-02       Impact factor: 5.156

8.  Mechanisms of catalysis and inhibition operative in the arginine deiminase from the human pathogen Giardia lamblia.

Authors:  Zhimin Li; Liudmila Kulakova; Ling Li; Andrey Galkin; Zhiming Zhao; Theodore E Nash; Patrick S Mariano; Osnat Herzberg; Debra Dunaway-Mariano
Journal:  Bioorg Chem       Date:  2009-06-13       Impact factor: 5.275

9.  Active site cysteine is protonated in the PAD4 Michaelis complex: evidence from Born-Oppenheimer ab initio QM/MM molecular dynamics simulations.

Authors:  Zhihong Ke; Yanzi Zhou; Po Hu; Shenglong Wang; Daiqian Xie; Yingkai Zhang
Journal:  J Phys Chem B       Date:  2009-09-24       Impact factor: 2.991

Review 10.  Strategies for the inhibition of gingipains for the potential treatment of periodontitis and associated systemic diseases.

Authors:  Ingar Olsen; Jan Potempa
Journal:  J Oral Microbiol       Date:  2014-08-18       Impact factor: 5.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.